Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

Ventripoint Announces Debt Settlement Agreements

By The Northwire Desk — AI Analysis Nov 06, 2025 · 08:50 VPT · 0.095 VentriPoint Diagnostics Ltd.
VPT · Price

Executive Summary

  • Ventripoint Diagnostics Ltd. will settle $542,591.50 of debt to arm’s‑length creditors by issuing 5,425,915 common shares at $0.10 per share.
  • The share issuance is subject to a four‑month and one‑day hold period and requires TSX Venture Exchange approval.
  • The transaction preserves cash for the company’s ongoing business development activities.

Key Details

  • Debt Amount: $542,591.50 total indebtedness to arm’s‑length creditors.
  • Share Issuance: 5,425,915 common shares at a price of $0.10 per share (aggregate gross consideration of $542,592).
  • Hold Period: Shares will be subject to a lock‑up of four months and one day from the date of issuance.
  • Purpose: Settlement of debt to conserve cash for product development and other corporate initiatives.
  • Regulatory Condition: Issuance is contingent upon approval by the TSX Venture Exchange.
  • Contact: Hugh MacNaught – [email protected] – 604‑671‑4201

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from VentriPoint Diagnostics Ltd.

Jun 26, 2026 · 08:10

AI cardiac imaging startup scaling niche partnerships while navigating a critical $55k cash balance and negative working capital.

M&A / Property Jun 16, 2026 · 09:11

AI cardiac imaging startup scales commercial partnerships but remains cash-constrained and pre-revenue at scale.

Other Apr 28, 2026 · 08:00

Ventripoint Advances China Entry Amidst Persistent Dilution Concerns

Regulatory Apr 20, 2026 · 08:50

Ventripoint Wins Gold Edison Award But Cash Burn and Dilution Risks Persist

Other Apr 16, 2026 · 11:00

TSXV Venture Exchange Listed Cardiac Imaging Platform

M&A / Property Apr 01, 2026 · 22:50

Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

M&A / Property